Continuing Education Information

Continuing Education credits for the Symposium on Clinical Interventional Oncology (CIO) are provided by HMP Education.

The live activity will take place from September 20-22, 2024.

Please contact info@hmpglobal.com for any specific requests or more information.

Intended Learners

The Symposium on Clinical Interventional Oncology (CIO) is designed for interventional radiologists, surgeons, oncologists, and other healthcare professionals involved in the treatment of cancer or looking to expand into this arena.

Learning Objectives

After attending the Symposium on Clinical Interventional Oncology (CIO), participants should be able to: 

  • Describe catheter-based procedures to treat solid tumors, using the latest techniques and technologies
  • Assess the most appropriate therapeutic agent in catheter-directed therapy for hepatic malignancies
  • Demonstrate appropriate decision-making skills and techniques in image guided ablation involving tumors of the kidney, bone, liver, and lung
  • Review the role of Y90 radioembolization in the management of hepatic malignancies as well as understand dosimetry and advanced techniques
  • Understand the role of systemic therapy in management of various malignancies and its potential synergistic effects with locoregional therapies
  • Determine the most appropriate imaging modalities during assessment, treatment, and follow-up of patients
  • Learn the clinical data, outcomes, and complications of minimally invasive interventional oncology therapies
  • Describe important literature, analyze the evidence, and review the pros and cons for different IO therapies
  • Review controversies in interventional oncology and debate competing therapies including medical oncology, surgical and radiation therapies
  • Discuss novel and state of the art minimally invasive treatments for cancer

Accreditation Statement

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.

Credit Designation

Physicians

This live activity has been approved to award 17.75 AMA PRA Category 1 Credit™.

International Credit Recognition
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Bilateral reciprocal accreditation agreements exist between the Canadian Medical Association and the American Medical Association and the American Academy of Family Physicians.

The following Countries and Regions have reciprocity with the AMA/ACCME:

  • Bavarian Chamber of Physicians (Germany)
  • Bulgarian Union of Scientific Medical Societies (Bulgaria)
  • Canadian Medical Association (Canada)
  • Federation of Royal Colleges of Physicians (UK)
  • French National Medical Council (France)
  • Italian Federation of Scientific Medical Societies (Italy)
  • National CME Commission of the Italian Ministry of Health (Italy)
  • Royal College of Physicians and Surgeons of Canada (Canada)
  • Spanish Accreditation Council for CME (Spain)

Physician Assistants


AAPAHMP Education has been authorized by the American Academy of PAs (AAPA) to award 17.75 AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Nurses

This continuing nursing education live activity will award 17.75 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255.

Provider Statement

Provided by HMP Education, an HMP Global Company.

For questions regarding this educational activity, please call 609-371-1137 or email accreditation@hmpglobal.com.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Grievance Statement

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at accreditation@hmpglobal.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 770.751.7332/609.371.1137.

Privacy Policy

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2024 by HMP Education. All rights reserved

Commercial Support

The following companies have provided an educational grant in support of this activity:  

Boston Scientific*
Merck & Co., Inc., Rahway, NJ, USA.
Eisai Inc.
Varian Medical Systems, Inc.
Histosonics
Guerbet*

*Resident & Fellow Supporter

Note: Information contained herein is subject to change without notice.